Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. - Wikidata - awgldk - TriplyDB

Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.

Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.

http://www.wikidata.org/entity/Q33992633

about

Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action Need for a paradigm shift in therapeutic approaches to CNS injury Routes to covalent catalysis by reactive selection for nascent protein nucleophiles Suppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46-62.Physiological IgM class catalytic antibodies selective for transthyretin amyloid.Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradation Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.Specific anti-integrase abzymes from HIV-infected patients: a comparison of the cleavage sites of intact globular HIV integrase and two 20-mer oligopeptides corresponding to its antigenic determinants.Structural insight into the role of myelin basic protein in multiple sclerosis.The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.IVIg treatment reduces catalytic antibody titers of renal transplanted patients Why specific anti-integrase antibodies from HIV-infected patients can efficiently hydrolyze 21-mer oligopeptide corresponding to antigenic determinant of human myelin basic protein.Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.Autoantibodies with enzymatic properties in human autoimmune diseases.Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity Systemic lupus erythematosus: molecular cloning and analysis of 22 individual recombinant monoclonal kappa light chains specifically hydrolyzing human myelin basic protein.Systemic lupus erythematosus: molecular cloning and analysis of recombinant monoclonal kappa light chain NGTA2-Me-pro-ChTr possessing two different activities-trypsin-like and metalloprotease.Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.DNA-hydrolysing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections.Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.Systemic lupus erythematosus: molecular cloning and analysis of recombinant monoclonal kappa light chain NGTA1-Me-pro with two metalloprotease active centers.Multitarget selection of catalytic antibodies with β-lactamase activity using phage display.Constant domain-regulated antibody catalysis.Liposome-encapsulated peptides protect against experimental allergic encephalitis Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.Polyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis.Antibody-antigen pair probed by combinatorial approach and rational design: bringing together structural insights, directed evolution, and novel functionality.A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.How human IgGs against DNA recognize oligonucleotides and DNA.How human IgGs against myelin basic protein (MBP) recognize oligopeptides and MBP.Antibody-Mediated Catalysis in Infection and Immunity.Antibodies as predictors of autoimmune diseases and cancer.

P2860

Q26822611-3D586AF0-CDC1-4A69-BD6D-AD45FD2CACFC Q27025042-3956CFB9-6060-43D7-A453-3CA6C32FB733 Q30838921-FCF49AE8-5AEB-44EB-8656-A8BFE12A93EA Q33509141-E4EF939F-7031-4D04-BCC7-4ABDEA2BA45A Q33676625-108EBFD4-F24D-45AC-98F9-70CEA95DF9CA Q33793002-DE8F0B08-67C5-4B83-937E-411C8A297396 Q34266957-6ECF511B-8DCA-4578-9215-4218AA7AA6DA Q34560416-A9F17858-CF5A-4543-9424-19C042CB0933 Q34574625-89C1C681-4D29-4E4C-B19A-8519C5DCC630 Q34677183-B97652A7-EB7E-45E3-A4DE-2ECE4C55355E Q34962680-302EE15E-FDE1-423C-BD3E-4AA9DF606706 Q35077353-2FA2A12B-D0DE-4FF1-95E2-6E772B50626A Q35149485-DA578F3F-F37F-4F69-9FE4-C95DACDE524C Q35214200-E317577E-6D8F-4D65-994D-62477DE948FB Q35231795-E9637853-473A-439E-84CD-76E03C1F3E32 Q35551663-714AF710-5E25-4C43-A0F4-B09C1AF49E5A Q35600192-F1A0497E-E14F-43A7-A1DA-8ED21850F4F3 Q35691336-35F48F58-7223-42A7-A5CE-40EE5CF0AAD7 Q35721504-33B85E9B-308C-46F5-AC3D-4CE242349A88 Q35841936-ABF566C5-2447-4322-9F4F-904B9F2441EC Q35880109-ECFC5429-5423-440E-9498-5B83ACA097B9 Q36022441-8AC28435-EF09-49BB-A9D9-2D1F3D863E5D Q36174449-7949A5CD-8E6D-4854-85A2-6378A6DE4B4E Q36246066-F2134902-F71D-405A-8D72-8DB210A05E29 Q36332826-E30AD80E-2B13-4A0D-B205-04E6B81F1FC4 Q36482892-377B728E-5C99-41F9-9881-ADC0808C13AD Q36669883-09EDF245-CB3A-430D-B728-9181E7BA8ED8 Q36811368-3695D9FD-346D-4D5B-8C08-845C0BE68150 Q36905946-674DB8EC-9273-4B2C-AFD7-3579A0CB6B43 Q37000547-0D80A96D-650B-4B6E-8414-5A0A0A46429D Q37296340-B10B1201-AD3B-45CA-B0D9-6FC30E34695A Q37368151-61746C01-5BBD-4C53-9BD3-96BF4AA0602B Q37433442-50B40157-1F85-4D0C-9B63-A34BC79B1101 Q37475594-64D43A1D-BFF5-4366-AE6F-6562D93B00A6 Q38030235-4DE267BB-323A-41F9-95B9-33B233A6578E Q38290090-3D56EC91-CCCD-4EE8-BAF1-1C9613E97194 Q38291185-DB3F1F74-DA31-4560-AEC4-9E7ED25BFDEB Q38805503-8918D332-2D4D-4DA8-8660-55FD3B73FC32 Q39412526-E4025DF8-8C94-497F-AD2B-52B31F7DE86A Q40086168-896587DD-2C07-47B9-87F0-BDE929F591B1

P2860

Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.

http://www.wikidata.org/entity/Q33992633

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Autoantibodies to myelin basic ...... degradation of their antigen.

@ast

Autoantibodies to myelin basic ...... degradation of their antigen.

@en

type

label

Autoantibodies to myelin basic ...... degradation of their antigen.

@ast

Autoantibodies to myelin basic ...... degradation of their antigen.

@en

prefLabel

Autoantibodies to myelin basic ...... degradation of their antigen.

@ast

Autoantibodies to myelin basic ...... degradation of their antigen.

@en

P1433

Q33992633-FE283E4D-995C-4A01-98F3-205B96379E0C

P1476

Q33992633-7B0C0DE8-DED9-4771-A976-75A151E064BE

P2093

Q33992633-236CF6C3-350D-4FF9-A6B0-FBE46BF2C7D4

Q33992633-39E2A405-F152-4E82-AAEB-FC8A2CD0CAE2

Q33992633-4B128BCA-BC97-474D-A445-4722B4379021

Q33992633-539043CD-D250-4098-9A6F-3367B41B943A

Q33992633-7022F3E9-1F63-44E4-8AA3-F753372FC759

Q33992633-872C801C-1E02-40FD-ABB5-CE50045E9C36

Q33992633-94B9EDFA-7212-489A-B753-DA0C85C26224

Q33992633-9999B9D4-46E8-4559-A27A-B64A744D90DB

Q33992633-B673CD81-DB67-45C7-AC27-131D7538B591

Q33992633-B9CED981-8E06-4300-9538-53906D0A15B7

P2860

Q33992633-0C505039-8B46-4A9C-B3C5-12AE6946FB24

Q33992633-0E10FB02-0E24-4B3C-A73D-57C5A132AA6D

Q33992633-3B867022-C9CA-4908-8B41-A3E2282AA440

Q33992633-404CE61C-4912-4F41-A5D5-5D60421E684E

Q33992633-4A3FD680-42B2-4AB2-A73C-129DD187B204

Q33992633-6766A22C-3C3D-4C74-951D-E6324A22DAF5

Q33992633-6A8F5785-BC38-4FE6-AC8A-874CF9724EA0

Q33992633-721EA280-07F3-43A4-90E3-5ED0B5245281

Q33992633-72E2D811-899E-4840-8EB0-2A1C6242C56D

Q33992633-79B67AA5-8D61-4FDC-8B30-2C9E914EEE62

P304

Q33992633-CBC58283-9064-40BC-97F7-82F6AB59333C

P31

Q33992633-FB5F3BCC-9E48-41CD-9A1B-2969DB5D599E

P356

Q33992633-709B3761-8EE2-4275-AB61-C0772933DBAB

P407

Q33992633-69B8C00B-6359-4ED5-824B-C408E97A7847

P433

Q33992633-486D7EA7-EE2F-4BE3-96D6-90ECCDB53E7B

P478

Q33992633-1124D7B4-CC3A-4097-92A7-60C5CC512626

P50

Q33992633-012EEA08-5416-48E4-9E1D-D0AE373B4082

Q33992633-02CEA8B8-5B18-4009-982D-9F13F3A5075B

Q33992633-1D1DC3E8-0B92-4DE0-9507-8E972BF69B89

Q33992633-48ADB572-169F-4E16-9BAC-8E1E59550D56

Q33992633-E88CD956-2ADF-42C9-9125-CDF3258BF3AF

P577

Q33992633-3BA1A7D2-371C-4BCB-B731-2F9EB4B0BF2D

P5875

Q33992633-93C2534F-603C-4AEC-9827-42E421E96CE1

P698

Q33992633-53AB4C65-0351-46E0-99D7-7E7AB4515246

P921

Q33992633-DEB2157F-C026-4555-A2B5-FB043EC56934

P932

Q33992633-2C12F13F-8C20-4AD7-866D-CE8A44E485D8

P356

PNAS.0509849103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Autoantibodies to myelin basic ...... degradation of their antigen.

@en

P2093

Alain Friboulet

http://www.w3.org/2001/XMLSchema#string

Alexander G Gabibov

http://www.w3.org/2001/XMLSchema#string

Alexander Karavanov

http://www.w3.org/2001/XMLSchema#string

Alexey A Belogurov

http://www.w3.org/2001/XMLSchema#string

Bérangère Avalle

http://www.w3.org/2001/XMLSchema#string

Daniel Thomas

http://www.w3.org/2001/XMLSchema#string

Georgy B Telegin

http://www.w3.org/2001/XMLSchema#string

Inna N Kurkova

http://www.w3.org/2001/XMLSchema#string

Ivan I Vorobiev

http://www.w3.org/2001/XMLSchema#string

Maria A Lagarkova

http://www.w3.org/2001/XMLSchema#string

P2860

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain

Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3':5'-monophosphate-dependent protein kinase

The antibody-enzyme analogy. Comparison of enzymes and antibodies specific for phosphopyridoxyltyrosine

A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats

Diagnostic criteria for multiple sclerosis.

Immunomodulation by the copolymer glatiramer acetate.

The role of B cells and autoantibodies in multiple sclerosis.

Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation.

DNA hydrolyzing autoantibodies.

P304

281-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0509849103

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Herbert C. Morse

Marina Serebryakova

Natalia A. Ponomarenko

Alexander Petrenko

P577

2005-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7383217

http://www.w3.org/2001/XMLSchema#string

P698

16387849

http://www.w3.org/2001/XMLSchema#string

P921

P932

1324791

http://www.w3.org/2001/XMLSchema#string